Bone Marrow TransplantationPeripheral Blood Stem Cell TransplantationHematopoietic Stem Cell TransplantationTransplantation, HomologousTransplantation, AutologousGraft vs Host DiseaseTransplantation ConditioningHematopoietic Stem Cell MobilizationBone MarrowBone Marrow CellsGranulocyte Colony-Stimulating FactorHematopoietic Stem CellsLeukapheresisHematologic NeoplasmsTissue DonorsGraft SurvivalStem CellsStem Cell TransplantationB7 AntigensImmunosuppressive AgentsAntigens, CD34Whole-Body IrradiationBlood Component RemovalBusulfanCyclophosphamideCombined Modality TherapyMelphalanTransplantation ChimeraHistocompatibility TestingHistocompatibilityLeukemiaAnemia, AplasticRecurrenceBone Marrow PurgingMultiple MyelomaAntineoplastic Combined Chemotherapy ProtocolsLymphoma, Non-HodgkinHematopoiesisCord Blood Stem Cell TransplantationRemission InductionTime FactorsTransplantation, IsogeneicBone and BonesBlood CellsRetrospective StudiesCytomegalovirus InfectionsBone Marrow DiseasesEtoposideLeukemia, Myeloid, AcuteLeukemia, Myelogenous, Chronic, BCR-ABL PositiveBlood Cell CountBlood DonorsKidney TransplantationMyeloablative AgonistsSurvival AnalysisLeukocyte TransfusionLymphocyte DepletionLiver TransplantationSurvival RateHematologic DiseasesDisease-Free SurvivalPrecursor Cell Lymphoblastic Leukemia-LymphomaInfectionOpportunistic InfectionsAcute DiseaseTransplantationImmunosuppressionThiotepaCarbamatesSalvage TherapyAntineoplastic Agents, AlkylatingCytarabineCyclosporineTransplantation ImmunologyHodgkin DiseaseMyelodysplastic SyndromesFlow CytometryColony-Forming Units AssayImmunocompromised HostHLA AntigensLeukemia, MyeloidGraft RejectionFollow-Up StudiesLymphomaLeukocyte CountHepatic Veno-Occlusive DiseasePlatelet CountMice, Inbred C57BLCarmustineFatal OutcomeGraft vs Leukemia EffectCell DifferentiationCell SeparationImmunophenotypingVidarabineCells, CulturedNuclear FamilyNeoplasmsRecombinant ProteinsLymphocyte Transfusion